English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Pharmaceutical Interventions Are Being Investigated As Possible Treatment Options For COVID-19. Antimalarial Drugs-Hydroxychloroquine And Chloroquine Are Also Being Investigated In Clinical Trials Due To Their Antiviral Effects Though Their Efficacy In The Treatment Of COVID-19 Is Largely Inconclusive. This Study Assessed The Knowledge, Perception, And Practice Of Prescribing These Drugs In The Treatment Of COVID-19 By Practicing Medical Doctors In Nigeria. The Survey Was Conducted Online Using Google Forms Sent Via A Link On WhatsApp© And Facebook© Through The Authors’ Contacts To Medical Doctors In The Six Geo-Political Zones Of Nigeria From April-May 2020. Ethical Issues Were Addressed By Ensuring The Anonymity Of Respondents, Voluntary Participation, And Non-Incentivized. Descriptive Statistics Were Used To Determine The Mean And Frequencies Of Data Generated Using SPSS Version 22. Responses Were Obtained From 145 Medical Doctors With Mean Age Of 37.78±6.47 Years And 10.9±5.58 Years Of Practice Experience. All The Respondents Knew That The Virus Affects The Lungs. Over 48% Of The Doctors Believed In The Efficacy Of The Antimalarial Drugs, And More Than Half Of Them Thought It Would Be More Effective For Mild Disease Presentation. About 46.8% Of Respondents Agreed To Prescribe The Drug To COVID-19 Patients, And Most Based Their Decisions On Case Reports, Recommendations Of NCDC Or WHO. However, 75.9% Believed A Randomized Control Trial Should Be Conducted To Determine The Efficacy And Safety Of The Drugs. Practicing Doctors In Nigeria Are Knowledgeable On COVID-19, And Their Perceptions And Decision To Prescribe Antimalarial Drugs Are Largely Dependent On Clinical Trial Outcomes.

Assessment of Knowledge, Practice and Perception of Nigerian Medical Practitioners on COVID-19 and Its Treatment Using Antimalarial Drugs